Downbeat retail sales data and Treasury Secretary Scott Bessent's comments are adding to worries about the economy.
BMO Capital Markets assumed coverage on shares of Avidity Biosciences (NASDAQ:RNA – Free Report) in a research note issued to ...
Bank of Montreal’s veteran oil and gas analyst is making the case for a four-way mega merger in Western Canada’s Montney ...
BMO Capital Markets initiated coverage on Dyne Therapeutics (DYN, Financials) with an Outperform rating and a $50 price target, suggesting a strong upside from the company's current share price of ...
On Thursday, BMO Capital Markets sustained their Market Perform rating on Casey’s General Stores (NASDAQ:CASY), with a steady price target of $450.00. The convenience store chain, currently ...
BMO Capital Markets’ price objective indicates a potential upside of 13.91% from the stock’s previous close. Several other equities research analysts also recently commented on ECL.
U.S. services sector growth unexpectedly picked up in February and prices for inputs increased, which combined with a recent ...
Economists had expected the unemployment rate to climb back up to 6.7 per cent in February, according to consensus estimates ...
Stock market corrections of 10% hurt. But research shows that they often don't portend worse things ahead for stocks.
On Friday, BMO Capital Markets maintained its "Market Perform" rating and a $25.00 price target for Gap Inc. (NYSE:GAP) shares, above the current trading price of $19.48. According to InvestingPro ...
ECN Capital Corp. (TSX: ECN) ("ECN Capital” or the "Company”) today announced that it has entered into an agreement with a syndicate of underwriters (the "Underwriters”) led by CIBC Capital Markets, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results